Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:prostaglandins g'
(id=8317928 ; fe=en:prostaglandins g ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=1043 creation date=2017-07-25 touchdate=2025-07-24 23:16:35.000)
≈ 33 relations sortantes

  1. en:prostaglandins g -- r_associated #0: 39 / 1 -> en:chemical synthesis
    n1=en:prostaglandins g | n2=en:chemical synthesis | rel=r_associated | relid=0 | w=39
  2. en:prostaglandins g -- r_associated #0: 36 / 0.923 -> en:cellular secretion
    n1=en:prostaglandins g | n2=en:cellular secretion | rel=r_associated | relid=0 | w=36
  3. en:prostaglandins g -- r_associated #0: 35 / 0.897 -> en:genetic aspects
    n1=en:prostaglandins g | n2=en:genetic aspects | rel=r_associated | relid=0 | w=35
  4. en:prostaglandins g -- r_associated #0: 35 / 0.897 -> en:prostaglandin g2
    n1=en:prostaglandins g | n2=en:prostaglandin g2 | rel=r_associated | relid=0 | w=35
  5. en:prostaglandins g -- r_associated #0: 34 / 0.872 -> en:chemical aspects
    n1=en:prostaglandins g | n2=en:chemical aspects | rel=r_associated | relid=0 | w=34
  6. en:prostaglandins g -- r_associated #0: 34 / 0.872 -> en:immunology aspects
    n1=en:prostaglandins g | n2=en:immunology aspects | rel=r_associated | relid=0 | w=34
  7. en:prostaglandins g -- r_associated #0: 34 / 0.872 -> en:mechanism of action qualifier
    n1=en:prostaglandins g | n2=en:mechanism of action qualifier | rel=r_associated | relid=0 | w=34
  8. en:prostaglandins g -- r_associated #0: 34 / 0.872 -> en:physiological aspects
    n1=en:prostaglandins g | n2=en:physiological aspects | rel=r_associated | relid=0 | w=34
  9. en:prostaglandins g -- r_associated #0: 34 / 0.872 -> en:prostaglandin endoperoxides
    n1=en:prostaglandins g | n2=en:prostaglandin endoperoxides | rel=r_associated | relid=0 | w=34
  10. en:prostaglandins g -- r_associated #0: 32 / 0.821 -> en:analysis aspect
    n1=en:prostaglandins g | n2=en:analysis aspect | rel=r_associated | relid=0 | w=32
  11. en:prostaglandins g -- r_associated #0: 32 / 0.821 -> en:in urine
    n1=en:prostaglandins g | n2=en:in urine | rel=r_associated | relid=0 | w=32
  12. en:prostaglandins g -- r_associated #0: 31 / 0.795 -> en:contraindications aspect
    n1=en:prostaglandins g | n2=en:contraindications aspect | rel=r_associated | relid=0 | w=31
  13. en:prostaglandins g -- r_associated #0: 31 / 0.795 -> en:therapeutic use - qualifier
    n1=en:prostaglandins g | n2=en:therapeutic use - qualifier | rel=r_associated | relid=0 | w=31
  14. en:prostaglandins g -- r_associated #0: 31 / 0.795 -> en:toxicity aspects
    n1=en:prostaglandins g | n2=en:toxicity aspects | rel=r_associated | relid=0 | w=31
  15. en:prostaglandins g -- r_associated #0: 30 / 0.769 -> en:15-ketoprostaglandin g2
    n1=en:prostaglandins g | n2=en:15-ketoprostaglandin g2 | rel=r_associated | relid=0 | w=30
  16. en:prostaglandins g -- r_associated #0: 30 / 0.769 -> en:agonists
    n1=en:prostaglandins g | n2=en:agonists | rel=r_associated | relid=0 | w=30
  17. en:prostaglandins g -- r_associated #0: 30 / 0.769 -> en:aspects of radiation effects
    n1=en:prostaglandins g | n2=en:aspects of radiation effects | rel=r_associated | relid=0 | w=30
  18. en:prostaglandins g -- r_associated #0: 30 / 0.769 -> en:metabolic aspects
    n1=en:prostaglandins g | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=30
  19. en:prostaglandins g -- r_associated #0: 30 / 0.769 -> en:standards characteristics
    n1=en:prostaglandins g | n2=en:standards characteristics | rel=r_associated | relid=0 | w=30
  20. en:prostaglandins g -- r_associated #0: 29 / 0.744 -> en:exposure as collected domain
    n1=en:prostaglandins g | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=29
  21. en:prostaglandins g -- r_associated #0: 29 / 0.744 -> en:poisoning aspects
    n1=en:prostaglandins g | n2=en:poisoning aspects | rel=r_associated | relid=0 | w=29
  22. en:prostaglandins g -- r_associated #0: 28 / 0.718 -> en:bioformation
    n1=en:prostaglandins g | n2=en:bioformation | rel=r_associated | relid=0 | w=28
  23. en:prostaglandins g -- r_associated #0: 28 / 0.718 -> prostaglandine g
    n1=en:prostaglandins g | n2=prostaglandine g | rel=r_associated | relid=0 | w=28
  24. en:prostaglandins g -- r_associated #0: 27 / 0.692 -> en:aspects of adverse effects
    n1=en:prostaglandins g | n2=en:aspects of adverse effects | rel=r_associated | relid=0 | w=27
  25. en:prostaglandins g -- r_associated #0: 27 / 0.692 -> en:deficiency aspects
    n1=en:prostaglandins g | n2=en:deficiency aspects | rel=r_associated | relid=0 | w=27
  26. en:prostaglandins g -- r_associated #0: 27 / 0.692 -> en:in blood
    n1=en:prostaglandins g | n2=en:in blood | rel=r_associated | relid=0 | w=27
  27. en:prostaglandins g -- r_associated #0: 27 / 0.692 -> en:prostaglandins h
    n1=en:prostaglandins g | n2=en:prostaglandins h | rel=r_associated | relid=0 | w=27
  28. en:prostaglandins g -- r_associated #0: 27 / 0.692 -> en:taxonomic
    n1=en:prostaglandins g | n2=en:taxonomic | rel=r_associated | relid=0 | w=27
  29. en:prostaglandins g -- r_associated #0: 27 / 0.692 -> prostaglandines g
    n1=en:prostaglandins g | n2=prostaglandines g | rel=r_associated | relid=0 | w=27
  30. en:prostaglandins g -- r_associated #0: 26 / 0.667 -> en:historical aspects qualifier
    n1=en:prostaglandins g | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=26
  31. en:prostaglandins g -- r_associated #0: 26 / 0.667 -> en:in cerebrospinal fluid
    n1=en:prostaglandins g | n2=en:in cerebrospinal fluid | rel=r_associated | relid=0 | w=26
  32. en:prostaglandins g -- r_associated #0: 26 / 0.667 -> en:pharmacokinetic aspects
    n1=en:prostaglandins g | n2=en:pharmacokinetic aspects | rel=r_associated | relid=0 | w=26
  33. en:prostaglandins g -- r_associated #0: 1 / 0.026 -> en:organic chemical
    n1=en:prostaglandins g | n2=en:organic chemical | rel=r_associated | relid=0 | w=1
≈ 33 relations entrantes

  1. en:pharmacokinetic aspects --- r_associated #0: 31 --> en:prostaglandins g
    n1=en:pharmacokinetic aspects | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=31
  2. prostaglandines g --- r_associated #0: 31 --> en:prostaglandins g
    n1=prostaglandines g | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=31
  3. en:15-ketoprostaglandin g2 --- r_associated #0: 30 --> en:prostaglandins g
    n1=en:15-ketoprostaglandin g2 | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=30
  4. en:standards characteristics --- r_associated #0: 30 --> en:prostaglandins g
    n1=en:standards characteristics | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=30
  5. en:agonists --- r_associated #0: 29 --> en:prostaglandins g
    n1=en:agonists | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=29
  6. en:prostaglandin endoperoxides --- r_associated #0: 29 --> en:prostaglandins g
    n1=en:prostaglandin endoperoxides | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=29
  7. en:aspects of adverse effects --- r_associated #0: 28 --> en:prostaglandins g
    n1=en:aspects of adverse effects | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=28
  8. en:genetic aspects --- r_associated #0: 28 --> en:prostaglandins g
    n1=en:genetic aspects | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=28
  9. en:in blood --- r_associated #0: 28 --> en:prostaglandins g
    n1=en:in blood | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=28
  10. en:mechanism of action qualifier --- r_associated #0: 28 --> en:prostaglandins g
    n1=en:mechanism of action qualifier | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=28
  11. en:poisoning aspects --- r_associated #0: 28 --> en:prostaglandins g
    n1=en:poisoning aspects | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=28
  12. en:prostaglandin g2 --- r_associated #0: 28 --> en:prostaglandins g
    n1=en:prostaglandin g2 | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=28
  13. en:chemical synthesis --- r_associated #0: 27 --> en:prostaglandins g
    n1=en:chemical synthesis | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=27
  14. en:deficiency aspects --- r_associated #0: 27 --> en:prostaglandins g
    n1=en:deficiency aspects | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=27
  15. en:physiological aspects --- r_associated #0: 27 --> en:prostaglandins g
    n1=en:physiological aspects | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=27
  16. prostaglandine g --- r_associated #0: 27 --> en:prostaglandins g
    n1=prostaglandine g | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=27
  17. en:bioformation --- r_associated #0: 26 --> en:prostaglandins g
    n1=en:bioformation | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=26
  18. en:prostaglandins h --- r_associated #0: 26 --> en:prostaglandins g
    n1=en:prostaglandins h | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=26
  19. en:therapeutic use - qualifier --- r_associated #0: 26 --> en:prostaglandins g
    n1=en:therapeutic use - qualifier | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=26
  20. en:toxicity aspects --- r_associated #0: 26 --> en:prostaglandins g
    n1=en:toxicity aspects | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=26
  21. en:exposure as collected domain --- r_associated #0: 25 --> en:prostaglandins g
    n1=en:exposure as collected domain | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=25
  22. en:historical aspects qualifier --- r_associated #0: 25 --> en:prostaglandins g
    n1=en:historical aspects qualifier | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=25
  23. en:chemical aspects --- r_associated #0: 24 --> en:prostaglandins g
    n1=en:chemical aspects | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=24
  24. en:contraindications aspect --- r_associated #0: 24 --> en:prostaglandins g
    n1=en:contraindications aspect | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=24
  25. en:in cerebrospinal fluid --- r_associated #0: 24 --> en:prostaglandins g
    n1=en:in cerebrospinal fluid | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=24
  26. en:in urine --- r_associated #0: 24 --> en:prostaglandins g
    n1=en:in urine | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=24
  27. en:analysis aspect --- r_associated #0: 23 --> en:prostaglandins g
    n1=en:analysis aspect | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=23
  28. en:aspects of radiation effects --- r_associated #0: 23 --> en:prostaglandins g
    n1=en:aspects of radiation effects | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=23
  29. en:metabolic aspects --- r_associated #0: 22 --> en:prostaglandins g
    n1=en:metabolic aspects | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=22
  30. en:taxonomic --- r_associated #0: 22 --> en:prostaglandins g
    n1=en:taxonomic | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=22
  31. en:cellular secretion --- r_associated #0: 21 --> en:prostaglandins g
    n1=en:cellular secretion | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=21
  32. en:immunology aspects --- r_associated #0: 21 --> en:prostaglandins g
    n1=en:immunology aspects | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=21
  33. taxinomique --- r_associated #0: 10 --> en:prostaglandins g
    n1=taxinomique | n2=en:prostaglandins g | rel=r_associated | relid=0 | w=10
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr